Gerard C M Linssen
Overview
Explore the profile of Gerard C M Linssen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
1167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
van Vliet D, Ploumen E, Pinxterhuis T, Doggen C, Aminian A, Schotborgh C, et al.
Clin Res Cardiol
. 2025 Mar;
PMID: 40035811
Background: Percutaneous coronary intervention (PCI) with new-generation drug-eluting stents is increasingly performed in elderly patients, who generally have more comorbidities and more technically challenging target lesions. Nevertheless, there is a...
2.
Sex and age-specific 10-year mortality after coronary stenting: an analysis of two randomized trials
Pinxterhuis T, Ploumen E, Doggen C, van Vliet D, Kok M, Zocca P, et al.
Eur Heart J Open
. 2025 Feb;
5(1):oeaf006.
PMID: 39959922
Aims: Over time, clinical outcome after percutaneous coronary intervention (PCI) with contemporary drug-eluting stents (DES) has improved. While most patients survive for many years after PCI, data on potential sex...
3.
Matsumoto S, Jhund P, Henderson A, Bauersachs J, Claggett B, Desai A, et al.
J Am Coll Cardiol
. 2025 Jan;
85(2):173-185.
PMID: 39814476
Background: An initial decline in estimated glomerular filtration rate (eGFR) often leads to reluctance to continue life-saving therapies in patients with heart failure (HF). Objectives: The goal of this study...
4.
Pinxterhuis T, Ploumen E, Kok M, Schotborgh C, Anthonio R, Roguin A, et al.
Cardiovasc Interv Ther
. 2024 Dec;
40(2):287-295.
PMID: 39699832
Patients undergoing percutaneous coronary intervention (PCI) may experience bleeding events. Bleeding risk is increased in patients with comorbid peripheral arterial disease (PADs). To evaluate whether PCI patients with PADs have...
5.
Butt J, Henderson A, Jhund P, Claggett B, Desai A, Lay-Flurrie J, et al.
J Am Coll Cardiol
. 2024 Dec;
85(2):140-155.
PMID: 39665701
Background: Obesity is associated with excessive adipocyte-derived aldosterone secretion, independent of the classical renin-angiotensin-aldosterone cascade, and mineralocorticoid receptor antagonists may be more effective in patients with heart failure (HF) and...
6.
Solomon S, McMurray J, Vaduganathan M, Claggett B, Jhund P, Desai A, et al.
N Engl J Med
. 2024 Sep;
391(16):1475-1485.
PMID: 39225278
Background: Steroidal mineralocorticoid receptor antagonists reduce morbidity and mortality among patients with heart failure and reduced ejection fraction, but their efficacy in those with heart failure and mildly reduced or...
7.
Allach Y, Barry-Loncq de Jong M, Clephas P, van Gent M, Brunner-La Rocca H, Szymanski M, et al.
Eur J Heart Fail
. 2024 Jun;
26(8):1736-1744.
PMID: 38825743
Aims: Heart failure (HF), a global pandemic affecting millions of individuals, calls for adequate predictive guidance for improved therapy. Congestion, a key factor in HF-related hospitalizations, further underscores the need...
8.
Ploumen E, Semedo E, Doggen C, Schotborgh C, Anthonio R, Danse P, et al.
Neth Heart J
. 2024 May;
32(6):254-261.
PMID: 38776038
Background: Several ethnic minorities have an increased risk of cardiovascular events, but previous European trials that investigated clinical outcome after coronary stenting did not assess the patients' ethnic background. Aims:...
9.
Malgie J, Wilde M, Clephas P, Emans M, Koudstaal S, Schaap J, et al.
Eur J Heart Fail
. 2024 May;
26(7):1549-1560.
PMID: 38734980
Aims: Despite clear guideline recommendations for initiating four drug classes in all patients with heart failure (HF) with reduced ejection fraction (HFrEF) and the availability of rapid titration schemes, information...
10.
Solomon S, Ostrominski J, Vaduganathan M, Claggett B, Jhund P, Desai A, et al.
Eur J Heart Fail
. 2024 May;
26(6):1334-1346.
PMID: 38733212
Aims: To describe the baseline characteristics of participants in the FINEARTS-HF trial, contextualized with prior trials including patients with heart failure (HF) with mildly reduced and preserved ejection fraction (HFmrEF/HFpEF)....